Cartalax 20 mg

For Research Only

Cartalax is a short synthetic peptide bioregulator that has been studied in laboratory and preclinical settings for its potential role in cartilage-related cellular signaling and tissue regulation. Research interest has focused on how Cartalax may influence gene-expression pathways associated with chondrocytes, extracellular matrix activity, and cartilage homeostasis.

Because of these properties, Cartalax is primarily investigated in experimental models related to connective tissue biology, cellular aging, and cartilage structure and function.